Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 25(10): 3859-3867, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-34109594

RESUMO

OBJECTIVE: The results of pioneering studies indicate that probiotics can alleviate menopausal symptoms (including cardiometabolic dysfunctions) and improve the quality of life of perimenopausal/postmenopausal women. However, the results of randomized control trials are scarce to evaluate whether the administration of probiotics could affect the balance of sex hormones during the menopause period. PATIENTS AND METHODS: In this randomized, double-blind, and placebo-controlled study, 48 perimenopausal and postmenopausal women received multispecies probiotic Sanprobi Barrier in a dose of 2.5 × 109 (CFU) for five weeks. Dietary guidelines were introduced in both groups simultaneously (~1800 kcal/per day, whole grain, no-wheat meals). The study aimed to assess the variations in follicle-stimulating hormone (FSH), estradiol (E2), cortisol (as the hypothalamic-pituitary-ovarian axis hormone), and the body mass during the intervention. RESULTS: At the endpoint, FSH level has increased significantly concerning the baseline after the probiotic intake (31.91 vs. 42.00 mIU/ml; p < 0.009). Also, in the placebo group, a strong trend to elevate FSH was observed (22.31 vs. 41.99 mIU/ml; p = 0.055). Body mass has crucially decreased in reference to the baseline in both groups (PRO: 27.90 vs. 26.30 kg/m2, p<0.001; PBO: 25.90 to 24.60 kg/m2, p<0.001). CONCLUSIONS: Probiotics affect FSH levels in perimenopausal women while simultaneously representing a non-invasive strategy to impact hormonal homeostasis. They could potentially have an impact on cardiometabolic health.


Assuntos
Hormônio Foliculoestimulante/sangue , Perimenopausa/sangue , Pós-Menopausa/sangue , Probióticos/uso terapêutico , Índice de Massa Corporal , Dieta , Método Duplo-Cego , Estradiol/sangue , Feminino , Humanos , Hidrocortisona/sangue , Pessoa de Meia-Idade
2.
Clin Exp Obstet Gynecol ; 43(6): 893-895, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-29944247

RESUMO

Ectopic pregnancy is the development of the embryo outside the uterine cavity. In recent years an increase in the incidence of ectopic pregnancies has been observed. It is mainly related to the increased number of IVF procedures. The most frequent localization is the ampulla of the fallopian tube. In cases of intramural or cornual ectopic pregnancies, many patients have a history of ectopic pregnancy on the same side or underwent partial salpingectomy in the past. Treatment of such pregnancies involves laparotomy and removal of the uterus or comu of the uterus. This case concerns a patient operated because of intramural pregnancy. She had a salpingectomy in the past because of tubal ectopic pregnancy on the same side. This case shows that even after removal of the fallopian tube there is still a risk of ectopic pregnancy in the intramural part of this tube.


Assuntos
Gravidez Intersticial/cirurgia , Gravidez Tubária/cirurgia , Salpingectomia , Útero/cirurgia , Adulto , Feminino , Humanos , Gravidez , Risco
3.
Eur J Gynaecol Oncol ; 36(3): 330-2, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26189263

RESUMO

Ovarian malignant tumours are mostly ovarian cancers. The most frequent ovarian benign lesions are mature teratomas. A very rare ovarian neoplasm is carcinoid. It mostly occurs as a component of mature teratoma, what causes rare diagnosis before surgery. Study presents the case of patient with primary ovarian carcinoid in mature teratoma of one ovary, co-existing with primary epithelial carcinoma of another ovary. Surgical treatment of carcinoid involves adnexectomy or hysterectomy with adnexa and removal of great omenturn, followed by chemotherapy and radiotherapy. In young women with early-stage tumours, treatment can be limited to adnexectomy followed by close monitoring. In the presented case, management associated with the diagnosis of ovarian carcinoid, resulted in the detection of early-stage ovarian epithelial cancer. This case seems to confirm the recommendations to take tissue samples from the other ovary for histopathological evaluation in cases of ovarian unilateral benign tumours.


Assuntos
Tumor Carcinoide/patologia , Neoplasias Císticas, Mucinosas e Serosas/patologia , Neoplasias Primárias Múltiplas/patologia , Neoplasias Ovarianas/patologia , Teratoma/patologia , Adulto , Feminino , Humanos , Estadiamento de Neoplasias
4.
Kidney Int ; 59(2): 631-6, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11168944

RESUMO

BACKGROUND: The XbaI polymorphism in the glucose transporter GLUT1 gene has been implicated in the development of diabetic nephropathy in Chinese type 2 diabetes patients. METHODS: To examine whether the XbaI polymorphism is involved in the development of diabetic nephropathy in Caucasian type 2 diabetes patients, a large case control study was performed. The study group of 444 patients with type 2 diabetes consisted of three subgroups: 162 patients with normoalbuminuria (only patients with duration of type 2 diabetes of at least 10 years after diagnosis); 150 with microalbuminuria; and 132 subjects with persistent proteinuria or chronic renal failure (CRF). The polymerase chain reaction (PCR)-based genotyping of the XbaI polymorphism was performed in each subject. RESULTS: The genotype distribution in the subgroups showed an increased frequency of the (+/+) genotype in patients with microalbuminuria (41%; OR 1.40, 95% CI, 0.89 to 2.24) and proteinuria/CRF (47%; OR 1.82, 95% CI, 1.13 to 2.93, P = 0.013) when compared with normoalbuminuria (33%). No difference in the genotype distribution was observed between type 2 diabetes patients and healthy controls. CONCLUSIONS: The results of this study in Caucasian patients with type 2 diabetes indicate that the XbaI(-) allele in the GLUT1 gene protects against the development of diabetic nephropathy. Our results are in contrast to the case control study in Chinese patients with type 2 diabetes in which the presence of the XbaI(-) allele appeared to have a strong association with the development of diabetic nephropathy.


Assuntos
Diabetes Mellitus Tipo 2/genética , Predisposição Genética para Doença , Proteínas de Transporte de Monossacarídeos/genética , Idoso , Albuminúria/genética , Alelos , Estudos de Casos e Controles , Feminino , Frequência do Gene , Genótipo , Transportador de Glucose Tipo 1 , Humanos , Falência Renal Crônica/genética , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , Proteinúria/genética
5.
Pol Arch Med Wewn ; 103(3-4): 169-77, 2000.
Artigo em Polonês | MEDLINE | ID: mdl-11236244

RESUMO

UNLABELLED: The hallmark of immunological memory is a quick and effective response to a repeated antigen exposure. Virgin lymphocytes, with their surface receptors CD45RA+, CD45RO- are produced in primary lymphatic organs, then migrating to secondary lymphatic structures. Memory lymphocytes CD45RO+, CD45RA- produced in these organs migrate to non-lymphatic organs--a possible location of inflammatory process, thus enabling the immunological system to eliminate effectively the same antigen, when repeatedly present. The aim of the study was 1) to test the influence of hemodialysis on the number of virgin lymphocytes and/or memory lymphocytes; 2) whether such impact (if any) depends on the type of dialysis membrane used (cuprophan or polysulphon), 3) if the effect is different in patients with or without diabetes. Overall number of virgin T helper lymphocytes CD45RA+CD4+ was significantly lower in patients with end-stage renal disease, while the number of total CD45RO+, CD45RA- memory lymphocytes was significantly greater among patients with diabetic nephropathy, compared to normal control subjects. After 15 minutes of hemodialysis, number of virgin lymphocytes CD45RA+, CD45RO- (p < 0.001, p < 0.01) and their subclasses, as well as memory lymphocytes CD45RO+, CD45RA- were significantly decreased. After 15 minutes of hemodialysis with polysulphon membrane, the decrease in T virgin cytotoxic, B virgin CD45RA+CD4-, T memory cytotoxic as well as B memory CD45RO+CD4- lymphocytes was significantly lower, when compared with cuprophan membrane (p < 0.02). Among patients treated with cuprophan hemodialysis, the decrease of T helper memory CD45RO+CD4+ lymphocytes was significantly lower in patients with diabetic nephropathy, than in non-diabetic patients. CONCLUSIONS: In all patients with end-stage renal disease, the impact of hemodialysis on the number of memory lymphocytes CD45RO+, CD45RA-, as well as virgin lymphocytes CD45RA+, CD45RO- was shown, but the effect was less profound during hemodialysis with polysulphon membrane, compared to cuprophan. The presence of diabetic nephropathy effects the hemodialysis-induced changes in the number of T memory helper CD45RO+ CD45RO+CD4+ lymphocytes, with no impact on other subclasses of the examined cells.


Assuntos
Celulose/análogos & derivados , Falência Renal Crônica/imunologia , Falência Renal Crônica/terapia , Contagem de Linfócitos , Diálise Renal , Adulto , Linfócitos B/imunologia , Nefropatias Diabéticas/imunologia , Nefropatias Diabéticas/terapia , Feminino , Humanos , Memória Imunológica , Antígenos Comuns de Leucócito/imunologia , Linfócitos/imunologia , Masculino , Membranas Artificiais , Pessoa de Meia-Idade , Polímeros , Sulfonas , Linfócitos T Auxiliares-Indutores/imunologia
7.
Pol Merkur Lekarski ; 3(15): 135-8, 1997 Sep.
Artigo em Polonês | MEDLINE | ID: mdl-9461712

RESUMO

The authors report a case of cavernous sinus thrombosis of paranasal sinus origin. Such complication developed in a case of chronic exacerbated sinusitis and blockade of sinus orifices by polyps. Timely and effective surgical intervention combined with medical treatment achieved complete remission even of the complications of cavernous sinus thrombosis.


Assuntos
Seio Cavernoso , Pólipos Nasais/complicações , Trombose dos Seios Intracranianos/etiologia , Sinusite/complicações , Adulto , Doença Crônica , Humanos , Masculino , Pólipos Nasais/terapia , Trombose dos Seios Intracranianos/terapia , Sinusite/terapia
9.
Pol Arch Med Wewn ; 92(5): 400-7, 1994 Nov.
Artigo em Polonês | MEDLINE | ID: mdl-7885988

RESUMO

In patients with chronic renal failure treated with haemodialysis many disorders of specific and unspecific immunity were observed. Several different parameters such as direct interaction with dialyzer membrane, hypersensitivity to components within the membrane, complement activation, or presence of endotoxins in the dialysis fluid or water supply can activate the immune system during haemodialysis and cause immunity disorders. This study aimed to compare the biocompatibility of two different dialysis membranes on the ground of the influence on the counts of immunity cells in the first hour of haemodialysis when the interaction between blood and membrane were the greatest. In 18 patients with CRF granulocytes, monocytes, lymphocytes B and T, T4 and T8 cells were counted just before haemodialysis, 15 minutes and 60 minutes after the start of haemodialysis. In all patients the investigation was done first using the cuprophane dialysis membrane and then using polysulfone dialysis membrane. The cell populations were differentiated by flow cytometry on Fascan using the conjugated monoclonal antibodies. During the first 15 minutes of haemodialysis with cuprophane membrane the amount of all investigated cells populations decreased significantly. With polysulfone membrane only monocytes decreased significantly in the first 15 minutes of haemodialysis. These results indicate that the polysulfone membrane is more biocompatible than the cuprophane one and suggest that using the biocompatible membranes some disorders of immunity system in this patients can be prevented.


Assuntos
Celulose/análogos & derivados , Falência Renal Crônica/imunologia , Falência Renal Crônica/terapia , Leucócitos/efeitos dos fármacos , Membranas Artificiais , Polímeros/farmacologia , Diálise Renal/instrumentação , Sulfonas/farmacologia , Adulto , Materiais Biocompatíveis/farmacologia , Celulose/farmacologia , Feminino , Citometria de Fluxo , Humanos , Contagem de Leucócitos/efeitos dos fármacos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...